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Mycobacterium tuberculosis (Mtb) infects about 8 million people every year and causes death 
of about 2-3 million (Raviglione, 2003). In recent times, there has been a wider spread of 
tuberculosis, mainly due to emergence of multi drug resistance (MDR) bacilli and enhanced 
susceptibility to the disease by patients infected with human immunodeficiency virus (HIV) 
(Elliot et al., 1995; Chintu and Mwinga, 1999). Transmission of the infection by Mtb bacilli is 
air borne and occurs through inhalation of aerosol containing the bacilli exhaled by 
coughing, sneezing or spitting by patients suffering from pulmonary tuberculosis. The 
inhaled bacilli are engulfed by the alveolar macrophages, where the bacilli are able to persist 
successfully in a latent or proliferating state. This persistence is achieved by modulation of 
several intracellular signaling pathways in order to create a suitable environment for the 
bacilli. The interplay of mycobacteria with host signaling pathways is a complex and 
dynamic process that is not clearly understood. Mtb secretes several molecules that 
modulate the signaling pathways (Koul et al., 2004). Most of these molecules commonly 
target macrophages, which helps the bacilli to evade innate immune response and 
propagate throughout the system (Rosenberger and Finlay, 2003). 
The proteins secreted by Mtb have gained attention in recent years as putative vaccine and 
diagnostic candidates (Harboe et al., 1996; Colangeli et al., 2000). But there have been recent 
reports about their role in modulation of macrophage signaling pathways leading to 
compromise of macrophage functions (Trajkovic et al., 2002; Pym et al., 2003; Guinn et al., 
2004). Thus the secretory proteins can act as risk or virulent factors too. This notion is also 
supported by the fact that only live but not dead bacilli can down regulate macrophage 
functions (Malik et al., 2001). In this chapter, we focus our discussion on the role of the 
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proteins secreted by region of difference-1 (RD-1), the region that is deleted in all the strains 
of M. bovis BCG. 
2. Genetic architecture of Region of Difference-1 (RD-1) 
Comparative genome analysis using DNA microarray, bacterial artificial chromosomes 
(BAC) and the subtractive hybridization between virulent and attenuated strains of Mtb 
complex and M. bovis BCG identified several regions of difference (RD) (Behr et al., 1999; 
Gordon et al., 1999; Mahairas et al., 1996). A gene segment of 9.5kb that encompasses nine 
open reading frames (ORF) of Rv3871-Rv3879c is present in virulent strains of Mtb, and 
which is deleted consistently in all the strains of M. bovis BCG (Cole et al., 1998). This region 
was designated as RD-1. Two of these ORFs, Rv3874 and Rv3875, encode 10-kDa culture 
filtrate protein (CFP-10) and 6-kDa early secreted antigenic target (ESAT-6) protein 
respectively. Interestingly, deletion of the RD-1 fragments from Mtb causes loss of its 
virulence, while introduction of the RD-1 locus into M. bovis BCG or M. microti resulted in 
increased virulence and survival properties (Behr, 2002; Pym et al., 2002; Lewis et al., 2003; 
Demangel et al., 2005). This review will focus on the role of these two proteins in 
modulation of the macrophage signaling pathways and macrophage functions for the 
bacteria to persist for longer time. We also discuss about the potential role of these proteins 
as vaccine candidates owing to their high immunogenicity. 
3. Structural biology of CFP-10 and ESAT-6 
The ORFs Rv3874 and Rv3875 encoding CFP10 and ESAT6 respectively are 
cotranscribed into a single RNA product (Cole et al., 1998). Nuclear magnetic resonance 
(NMR) spectroscopy showed that CFP10 exhibits very little secondary structure and 
consists mostly of random coils, which are unstructured. The ESAT6, on the other hand 
has 75% secondary structure in the form of -helices (Renshaw et al., 2002). One 
interesting study showed that CFP10 and ESAT6 forms a tight 1:1 complex where both 
proteins adopt more stable and folded configuration than the native moieties (Renshaw 
et al., 2002; Lightbody et al., 2004). The complex formation between the two proteins is 
hydrophobic in nature and led to a significant increase in the helical content of the two 
proteins. Inside the core of the complex, helix-turn-helix motifs of the two proteins form 
a quad-helix bundle (Renshaw et al., 2005). Within the complex, the flexible C-terminus 
of CFP-10 is involved in binding to the cell surface. This was confirmed by the fact that 
deletion 87 amino acids at C-terminus of CFP-10 inhibited the binding of complex to the 
cell surface, while deletion of the same in ESAT-6 had no effect (Renshaw et al., 2005). 
The complex formation between the two proteins was reversible and the complex broke 
down to individual proteins at 53.40C. The complex was also shown to be more stable to 
proteolytic digestion by trypsin (Meher at al., 2006). The enhanced stability to 
proteolytic digestion caused lower T cell activation compared to ESAT-6 alone (Marei et 
al., 2005). ESAT-6 protein was also found to have auto-proteolytic activity; it can self 
cleave-off six amino acids at the C-terminus which are responsible for its binding to the 
cell surface. A mutant ESAT-6 lacking these six amino acids was unable to bind to cell 
surface (Pathak et al., 2007). 
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4. Use of CFP10 and ESAT6 as tools for diagnosis  
and vaccine 
CFP-10 and ESAT-6 were identified in a screen to identify the proteins present in culture 
filtrates of Mtb and M. bovis BCG, which could induce T cell mediated response. (Andersen 
et al., 1991a; Andersen et al., 1991b; Andersen et al., 1994; Weldingh et al., 1998; Weldingh et 
al., 1999). The screen yielded six low molecular weight antigens viz. Rv3871, Rv3872, 
Rv3873, CFP-10, ESAT-6 and Rv3878. These antigens when expressed and purified as 
recombinant proteins gave strong humoral response in tuberculous guinea pigs while only 
two antigens i.e. CFP-10 and ESAT-6 showed strong delayed type hypersensitivity (DTH) 
reaction in the guinea pigs (Weldingh et al., 1999). CFP10 and ESAT6 are potent T cell 
antigens and induce strong T cell response. In mice infected with Mtb, CFP-10 specific T 
cells were observed at quite early stage of infection in lungs. These T cells were activated by 
CFP-10 epitopes and were recruited in large numbers (Kamath et al., 2004). This resulted in 
production of large amounts of interferon- (IFN-). Recombinant CFP-10 has also been 
shown to be a potent T cell antigen, inducing T cell proliferation and IFN- production in 
peripheral blood mononuclear cells in about 70% of purified protein derivative (PPD) 
positive asymptomatic individuals. CFP-10 was also shown to induce delayed type 
hypersensitivity (DTH) in Mtb infected guinea pigs but not in M. bovis BCG infected guinea 
pigs (Colangeli et al., 2000). ESAT-6 is also a RD-1 antigen inducing robust levels of IFN- by 
T cells in early stages of M. tuberculosis infection (Porsa et al., 2006; Ravn et al., 1999; Skjot et 
al., 2000; de Jong et al., 2006). Two different T cell epitopes were observed in mice, which 
were recognized by different MHCII molecules under different circumstances (Dietrich et 
al., 2005). 
5. Macrophage subversion by CFP10  
and ESAT6 
Despite their well-known role as T cell antigens, CFP10 and ESAT6 modulate several 
pathways inside the macrophage, thereby creating a suitable environment to persist 
inside the host cell. Studies from our lab have shown that CFP-10 and ESAT-6 
downregulates the production of reactive oxygen species (ROS) inside the macrophages; 
which in turn dampens the NF-ĸB transactivation property (Ganguly et al., 2008a, 
Ganguly et al., 2008b). The inhibition of ROS production was greater with the 
CFP10:ESAT6 complex compared to the individual proteins. Most of the effects of these 
proteins seem to be mediated by Toll-like receptors (TLR). Analysis of global phospho-
proteome in CFP-10 treated J774.1 macrophages showed that CFP-10 caused de-
phosphorylation of a large number of macrophage proteins (Basu et al., 2006; Basu et al., 
2009). The de-phsophorylation occurs due to increase in activity of membrane tyrosine 
phosphatases SHP-1 and SHP-2 (Src homology domain proteins). The increased 
phosphatase activity is due to reduction in production of ROS inside the macrophages. 
The ROS production in macrophages occurs through NADPH oxidase pathway. These 
observations suggest that upon binding of CFP-10 and ESAT-6 to macrophage surface, 
Mtb is able to reduce the burst of ROS inside the cell which contributes to bactericidal 
activity. Thus it might be one of the survival strategies of the bacilli. Mtb contains several 
enzymes to deal with the ROS/oxidative burst like catalase, peroxidase (Kat) (Sherman et 
www.intechopen.com
 
Understanding Tuberculosis – Deciphering the Secret Life of the Bacilli 
 
120 
al., 1995; Manca et al., 1999; Ng et al., 2004) as well as superoxide dismutases Sod A and 
Sod C (Piddington et al., 2001; Zhang et al., 1991). ESAT-6 was also found to inhibit 
mitogen activated kinase/extracellular signal regulated kinases 1/2 (MAPK/ERK1/2). 
This occurs due to some phosphatase activity in the nucleus which dephosphorylates 
ERK1/2. This resulted in reduction in lipopolysaccharide (LPS) induced expression of 
transcription factor c-myc (Ganguly et al., 2007). ESAT-6 also reduced the LPS-induced 
expression of several genes like IL-1β, Bax, Icam-1 and tnfr-1. Recent studies have shown 
that ESAT-6 binds to toll-like receptor-2 (TLR2) on the macrophage surface; and the six 
amino acids at the C-terminus of the protein are critical for its TLR2 binding (Pathak et al., 
2007). This binding caused inactivation of transcription factors interferon regulatory 
factors (IRF) and NF-ĸB. Recent observations from our lab have shown that ESAT-6 
down-regulates IFN- inducible expression of type I and type IV isomers of MHC class II 
transactivator (CIITA) in macrophages (Kumar et al., 2011). Interestingly, the 
downregulation of type I CIITA was independent of TLR-2 while the effect on type IV 
CIITA was mediated through TLR-2. This suggests that ESAT-6 may bind to other TLRs or 
some other receptor on macrophages. Another study has shown that ESAT-6 was able to 
induce apoptosis in human monocytic cell line THP-1 through activation of caspases 
(Derrick et al., 2007). It was also shown that ESAT-6 could induce pore formation on the 
surface of some cell types. 
Apart from macrophages, CFP-10 and ESAT-6 also modulate functions in dendritic cells 
(Natarajan et al., 2011; Trajkovic et al., 2004). Studies have shown that CFP-10 induced 
differentiation of bone marrow cells into dendritic cells (DC) and this involved activation of 
NF-ĸB (Latchumanan et al., 2002). CFP-10 also induced maturation of DCs, which caused 
downregulation of pro-inflammatory cytokines like interleukin-2 (IL-2) and IFN- 
(Natarajan et al., 2003). The CFP-10-differentiated and CFP-10-matured DCs when cultured 
with the Mtb whole-cell-extract primed T cells, showed reduced levels of pro-inflammatory 
cytokines IL-12p40 and IFN- along with elevated levels of anti-inflammatory cytokines IL-
10 and transforming growth factor  (TGF-) (Balkhi et al., 2004). Therefore CFP-10 primes 
DCs to have reduced efficacy to eliminate Mtb. CFP-10 also reduced ROS production during 
differentiation of DCs compared to the positive stimulator granulocyte macrophage colony-
an stimulating factor (GM-CSF). This downregulation of ROS resulted in increased survival 
of M. bovis BCG in these DCs (Sinha et al., 2006). The CFP-10 differentiated DCs also had 
reduced levels of chemokines RANTES and IP-10 upon infection by mycobacteria (Salam et 
al., 2008). 
6. Virulence linked to CFP10/ESAT6  
secretion 
CFP-10 and ESAT-6 proteins are secreted without any secretory signal sequence outside 
the host cell. The secretory apparatus that helps in the secretion of these two proteins 
have been characterized recently (Guinn et al., 2004; Fortune et al., 2005; Brodin et al., 
2006). The CFP10/ESAT6 secretion system is an active process involving several genes, 
some of them being ATP hydrolyzing chaperones (Stanley et al., 2003; Converse and Cox, 
2005; Stanley et al., 2007). Mutations in these genes caused significant reduction in 
virulence of Mtb in mouse model (Stanley et al., 2003; Majlessi et al., 2005). This 
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attenuation could be  due to the inhibition of CFP10/ESAT6 secretion, which further 
highlights the role of these two proteins in modulation of macrophage function. A study 
has shown that one of the components of ESX-1 secretion system, Rv3871 binds to the C-
terminus of CFP-10, and this facilitates the secretion of both CFP-10 and ESAT-6. 
Mutations at the C-terminus resulted in loss of binding to CFP-10 and impaired secretion 
of the two proteins (Champion et al., 2006). This suggests that CFP-10 and ESAT-6 might 
be secreted in the form of heterodimeric 1:1 complex out of the cell. The ESX-1 system 
has four paralogues in Mtb and some of them have been shown to be essential for in-
vitro growth of the bacilli (Simeone et al., 2009). In the ESX-1 system, Rv3868, Rv3869, 
Rv3870, Rv3871 and Rv3877 have been shown to be essential for CFP-10/ESAT-6 
secretion while loss of Rv3865 and partial loss of Rv3866 did not affect protein 
secretion, rather it caused attenuation of the bacilli (Brodin et al., 2006). Thus 
Rv3865/3866 might be some virulence factor that does not control ESAT-6 secretion. 
Studies with mutant bacilli showed that ESX-1 system is required for the induction of 
type I IFN induction that in turn contributes to the spread of the bacilli (Stanley et al., 
2007). In Mycobacterium marinum, the CFP-10/ESAT-6 secretion manipulates the 
phagosome-lysosome fusion. Mutations in this secretion system results in enhanced 
phagosome-lysosome fusion and reduced survival of mycobacteria (Tan et al., 2006; 
Majlessi et al., 2005; Champion et al., 2006; Xu et al., 2007; Lee et al., 2001). Analyses of 
deletion mutants of ESAT-6 have identified the key amino acids in complex formation, 
virulence and secretion (Brodin et al., 2005). The Trp-X-Gly motif on ESAT-6 is involved 
in complex formation with CFP-10, virulence and induction of specific T cell responses 
whereas mutations in the six amino acids at the C-terminus had no effect on secretion 
but caused attenuation. At acidic pH (as normally found in phagosomes), ESAT-6 
dissociated from its complexing partner CFP-10 and bound to liposomes, which caused 
lysis of the liposomes (de Jonge et al., 2007). This could be a mechanism for the Mtb to 
escape degradation within the phagosome. In dendritic cells, Mtb translocated from 
phagolysosome to cytoplasm, which is dependent upon the CFP-10/ESAT-6 secretion 
(van der Wel et al., 2007). This translocation resulted in the death of the host cell. 
7. Conclusions 
The interaction between mycobacteria and the host macrophage or dendritic cells is very 
complex and dependent on multiple factors. In this review, we have focused mainly on the 
modulating activities of CFP10/ESAT6, the molecules which are being evaluated as vaccine 
candidates, indicating that they may act like double-edged sword generating a favorable 
response from the host immune system. Apart from CFP-10/ESAT-6, several other protein 
antigens are also being reported which modulate the macrophage response to Mtb. Further 
studies are undergoing in our lab to elucidate the finer mechanisms by which these proteins 
function. 
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